Recent Updates on Diagnosis and Treatment of SARS-CoV-2: A Review
Pages : 1-8, doi: https://doi.org/10.54618/IJMAHS.2021111Download PDF
SARS-CoV-2 (severe acute respiratory syndrome – corona virus-2) emerged as a deadly virus and took approximately 3,422,907 deaths so far globally. The case fatality rate for SARS-CoV-2 is about 3-4% far below in comparison with the previous outbreaks including SARS-CoV and MERS-CoV. So far, the infection has reached in stage 3 i. e. community transmission in most of the countries, globally. The vaccine development is only the way by which the world could get out from this outbreak. Many vaccines have been developed by scientific communities up to the phase 3 trials and expecting some fruitful result out of it. In this review, we have discussed about the current status for COVID-19, the incubation and recovery period of the virus, structure of the virus, biological properties and its mechanism of replication. We have also discussed its health impact and current medicinal drugs including Remdesivir, Hydroxychloroquine, etc. and vaccines which are currently in trial phase, and lastly what could be the future plan to neutralize the effect of this outbreak.
Keywords: SARS-CoV-2, COVID-19, Structure, Strains, Biological Properties, Drugs,Vaccines, ACE2 Receptors.